Axogen, inc. announces new leadership appointments

Alachua, fla. and tampa, fla., aug. 08, 2024 (globe newswire) -- axogen, inc. (nasdaq: axgn), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that michael dale is appointed as chief executive officer and as a member of the axogen board of directors effective august 9, 2024. he succeeds karen zaderej, who will remain in an advisory role for nine months.
AXGN Ratings Summary
AXGN Quant Ranking